Razaz, N., Igland, J., Bjørk, M.-H., Joseph, K. S., Dreier, J. W., Gilhus, N. E., Gissler, M., Leinonen, M. K., Zoega, H., Alvestad, S., Christensen, J., & Tomson, T. (2024). Risk of perinatal and maternal morbidity and mortality among pregnant women with epilepsy. JAMA Neurology, 81(9), 985–995. https://doi.org/10.1001/jamaneurol.2024.2375
Christensen, J., Zoega, H., Leinonen, M. K., Gilhus, N. E., Gissler, M., Igland, J., Sun, Y., Tomson, T., Alvestad, S., Bjørk, M. H., & Dreier, J. W. (2024). Prenatal exposure to antiseizure medications and risk of epilepsy in children of mothers with epilepsy. JAMA Network Open, 7(2), e2356425. https://doi.org/10.1001/jamanetworkopen.2023.56425
Danelakis, A., Langseth, H., Nachev, P., Nelson, A., Bjørk, M. H., Matharu, M., Tronvik, E., May, A., & Stubberud, A. (2024). What drives citation counts and translational impact in headache research? A machine learning analysis. Cephalalgia, 44(5). https://doi.org/10.1177/03331024241241036
Alvestad, S., Dreier, J. W., Christensen, J., Igland, J., Gissler, M., Leinonen, M. K., Sun, Y., Zoega, H., Vegrim, H. M., Gilhus, N. E., Tomson, T., & Bjørk, M. H. (2024). Prenatal exposure to antiseizure medications and fetal growth: A population-based cohort study from the Nordic countries. The Lancet Regional Health – Europe, 38, 100849. https://doi.org/10.1016/j.lanepe.2024.100849
Bugge, C., Engebretsen, I., Kristiansen, I. S., Sæther, E. M., Lindberg-Schager, I., Arneberg, F., & Gilhus, N. E. (2024). Medical costs of treating myasthenia gravis in patients who need intravenous immunoglobulin (IVIg): A register-based study. Journal of Neurology, 272(1), 15. https://doi.org/10.1007/s00415-024-12768-5
Eid, K., Torkildsen, Ø., Aarseth, J., Cortese, M., Holmøy, T., Myhr, K. M., Riise, T., Wergeland, S., Gilhus, N. E., & Bjørk, M. H. (2024). Migraine in the multiple sclerosis prodrome: A prospective nationwide cohort study in pregnant women. The Journal of Headache and Pain, 25, 225. https://doi.org/10.1186/s10194-024-01754-1
Vegrim, H. M., Dreier, J. W., Igland, J., Alvestad, S., Gilhus, N. E., Gissler, M., Leinonen, M. K., Tomson, T., Zoega, H., Christensen, J., & Bjørk, M. H. (2024). Prescribing patterns for higher dose folic acid in pregnant women with epilepsy treated with antiseizure medication. Epilepsia, 65, 1698–1708. https://doi.org/10.1111/epi.17800
Aaberg, K. M., Vikin, T., Brannsether, B., Bjørk, M. H., Syvertsen, M. R., & Shirzadi, M. (2024). Nye norske begreper for epilepsisyndromer. Tidsskrift for Den norske legeforening, 144. https://doi.org/10.4045/tidsskr.24.0543
Aanestad, E., Beniczky, S., Olberg, H., & Brøgger, J. (2024). Unveiling variability: A systematic review of reproducibility in visual EEG analysis, with focus on seizures. Epileptic Disorders, 26(6), 827–839. https://doi.org/10.1002/epd2.20291
Bril, V., & Gilhus, N. E. (2024). Aging and infectious diseases in myasthenia gravis. Journal of the Neurological Sciences. Advance online publication. https://doi.org/10.1016/j.jns.2024.123314
Bruno, C., Cesta, C. E., Hjellvik, V., Ulrichsen, S. P., Bjørk, M. H., Esen, B. Ö., Gillies, M. B., Gissler, M., Havard, A., Karlsson, P., Karlstad, Ø., Leinonen, M. K., Nørgaard, M., Pearson, S.-A., Reutfors, J., Furu, K., Cohen, J. M., & Zoega, H. (2024). Association of antipsychotic use during pregnancy with risk of neurodevelopmental disorders and learning difficulties in children: A multinational cohort study. eClinicalMedicine, 70, 102531. https://doi.org/10.1016/j.eclinm.2024.102531
Engebretsen, I., Gilhus, N. E., Kristiansen, I. S., Sæther, E. M., Lindberg-Schager, I., Arneberg, F., & Bugge, C. (2024). The epidemiology and societal costs of myasthenia gravis in Norway: A non-interventional study using national registry data. European Journal of Neurology, 31(5), e16233. https://doi.org/10.1111/ene.16233
Gilhus, N. E., Andersen, H., Andersen, L. K., Boldingh, M., Laakso, S., Leopoldsdottir, M. O., Madsen, S., Piehl, F., Popperud, T. H., Punga, A. R., Schirakow, L., & Vissing, J. (2024). Generalized myasthenia gravis with acetylcholine receptor antibodies: A guidance for treatment. European Journal of Neurology, 31(5), e16229. https://doi.org/10.1111/ene.16229
Stemmerik, M. G., Tasca, G., Gilhus, N. E., … (2024). Biological biomarkers in muscle diseases relevant for follow-up and evaluation of treatment. Brain. Advance online publication. https://doi.org/10.1093/brain/awae323
Griffiths, S. T., Hepsø, S. W., Lee, M., Noszka, K., Wollertsen, Y. M., Holmaas, G., Kristensen, E., Eichele, T., Bjørk, M. H., & Hikmat, O. (2024). Refractory and super-refractory status epilepticus in children and adolescents: A population-based study from Western Norway. Seizure, 120, 116–123. https://doi.org/10.1016/j.seizure.2024.06.017
Hagen, K., Winsvold, B. S., Bjørk, M. H., Tronvik, E., Mathiesen, L. B., Ofte, H. K., Lundqvist, C., Sønnervik, J., & Bäcklund, N. (2024). Room for improvement in the follow-up for unilateral headache with autonomic symptoms. Tidsskrift for Den norske legeforening, 144(7). https://doi.org/10.4045/tidsskr.24.0184
Hikmat, O., Naess, K., Engvall, M., Klingenberg, C., Rasmussen, M., Brodtkorb, E., Ostergaard, E., de Coo, I., Pias-Peleteiro, L., Isohanni, P., Uusimaa, J., Majamaa, K., Kärppä, M., Ortigoza-Escobar, J. D., Tangeraas, T., Berland, S., Harrison, E., Biggs, H., Horvath, R., … Rahman, S. (2024). Status epilepticus in POLG disease: A large multinational study. Journal of Neurology. Advance online publication. https://doi.org/10.1007/s00415-024-12463-5
Kristensen, E., Mathisen, L., Berland, S., Klingenberg, C., Brodtkorb, E., Rasmussen, M., Tangeraas, T., Bliksrud, Y. T., Rahman, S., Bindoff, L. A., & Hikmat, O. (2024). Epidemiology and natural history of POLG disease in Norway: A nationwide cohort study. Annals of Clinical and Translational Neurology, 11(7), 1819–1830. https://doi.org/10.1002/acn3.52088
Leinonen, M. K., Igland, J., Dreier, J. W., Alvestad, S., Cohen, J. M., Gilhus, N. E., Gissler, M., Sun, Y., Tomson, T., Zoega, H., Vegrim, H. M., Christensen, J., & Bjørk, M. H. (2024). Socioeconomic differences in use of antiseizure medication in pregnancies with maternal epilepsy: A population-based study from Nordic universal healthcare systems. Epilepsia, 65(8), 2397–2411. https://doi.org/10.1111/epi.17812
Lindroos, J. L. V., Bjørk, M.-H., & Gilhus, N. E. (2024). Transient neonatal myasthenia gravis as a common complication of a rare disease: A systematic review. Journal of Clinical Medicine, 13(4), 1136. https://doi.org/10.3390/jcm13041136
Mancuso, M., Papadopoulou, M. T., Ng, Y. S., Ardissone, A., Bellusci, M., Bertini, E., Di Vito, L., Evangelista, T., Fons, C., Hikmat, O., Horvath, R., Klopstock, T., Kornblum, C., Lamperti, C., Licchetta, L., Molnar, M. J., Varhaug, K. N., O’Callaghan, M., … Rahman, S. (2024). Management of seizures in patients with primary mitochondrial diseases: Consensus statement from the InterERNs Mitochondrial Working Group. European Journal of Neurology, 31(7), e16275. https://doi.org/10.1111/ene.16275
McCallion, J., Borsi, A., Noel, W., Lee, J., Karmous, W., Sattler, S., Boggia, G. M., Hardy, E. J., Mitchell, C. R., Mitchell, S. A., & Gilhus, N. E. (2024). Systematic review of the patient burden of generalised myasthenia gravis in Europe, the Middle East, and Africa. BMC Neurology, 24(1), 61. https://doi.org/10.1186/s12883-024-03553-y
Mitter, V. R., Lupattelli, A., Bjørk, M. H., & Nordeng, H. M. E. (2024). Identification and characterization of migraine in pregnancy: A Norwegian registry-linkage study. Cephalalgia, 44(4). https://doi.org/10.1177/03331024241227584
Neugebauer, J., Reinson, K., Bellusci, M., Park, J. H., Hikmat, O., Bertini, E., Schiff, M., MetabERN PM-MD Consortium, & Rahman, S. (2024). Current global vitamin and cofactor prescribing practices for primary mitochondrial diseases: Results of a European reference network survey. Journal of Inherited Metabolic Disease. Advance online publication. https://doi.org/10.1002/jimd.12805
Poole, A. C., Stubberud, A., Simpson, M., Øie, L. R., Skalstad, E. T. V., Bjørk, M. H., Kristoffersen, E. S., Vetvik, K. G., Olsen, A., Larsen, I. C. K., Linde, M., Tronvik, E., & Meisingset, T. W. (2024). Biofeedback therapy using Cerebri for the prevention of migraine attacks in adults with episodic migraine (BioCer): A randomized, wait-list controlled trial – the study protocol. F1000Research, 13, 775. https://doi.org/10.12688/f1000research.145399.1
Stubberud, A., Borkenhagen, S., Oteiza, F., Dueland, A. N., Sæther, M., Bugge, C., Stovner, L. J., & Bjørk, M. H. (2024). Patterns of medication use in migraine in Norway: A nationwide registry-based observational study. Cephalalgia, 44(8). https://doi.org/10.1177/03331024241244601
Wiłkość-Dębczyńska, M., Liberacka-Dwojak, M., Rzepiński, Ł., & Gilhus, N. E. (2024). Diurnal cognitive functioning in patients with myasthenia gravis with the role of chronotype and depression: A pilot study. Postępy Psychiatrii i Neurologii, 33(2), 49–53. https://doi.org/10.5114/ppn.2024.141051